Experimental approaches and treatment of patients with GLP-1 analogs as well as dipeptidyl peptidase-IV (DPP-4) inhibitors, which inhibit the endopeptidase that rapidly degrades GIP and GLP-1, underline the multiple beneficial effects mediated by GLP-1, beyond blood glucose control
Quick answer: In head-to-head trials, tirzepatide (a dual GLP-1/GIP receptor agonist) produced greater weight loss than semaglutide (a single GLP-1 agonist) 20.2% vs 13.7% over 72 weeks in SURMOUNT-5 though semaglutides single-pathway selectivity keeps it valuable in research
Fourcroy JL
Most people dont see meaningful weight loss results until they move into higher doses
Generally, all of the prescription alternatives to Viagra can be effective, but individual response, side effect profile, and personal preference often guide the best choice, Dr
Apperloo EM, Neuen BL, Fletcher RA et al (2024) Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials